Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Recently, I was reading Luca Dezzani’s article “Patient Engagement: A Key Element in Pharmaceutical Marketing Strategy.” The article prompted me to think about how pharma companies continue to think about and discuss the idea of Patient Engagement, and.... Read More »

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Best Practices, LLC has recently completed “Benchmarking Regulatory Affairs Staffing & Performance Excellence in Medical Devices,” a new operational benchmarking study. After analyzing the data and probing the experience of 30 regulatory affairs (RA).... Read More »

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Read More »

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

At Pharma CI Conference 2015 in New Jersey, Best Practices, LLC’s CEO, Chris Bogan discussed the topic: Blockbuster Drugs Launch Evolution: Mapping Market - Entry Changes That Cause New Products to Stumble or Soar.... Read More »

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. Read More »

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. Read More »

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. Read More »

Brand Lifecycle Management: Strategies for Every Budget

Brand Lifecycle Management: Strategies for Every Budget

Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels from survey results of 25 executives representing 18 companies. Read More »

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple’s announcement that it will begin providing healthcare to its employees and families offers one more reason that Medical Affairs groups should ramp up their efforts to work with Large Employer groups. Read More »

 

Internal Communication Commandments to Live By

In order to improve an organization as a whole, it is critical to improve internal corporate communications. Best Practices, LLC’s work highlights how companies deliver their internal messages and find the proper balance between informing and educating employees. We have seen companies

Best Practices in Lifecycle Management: Maximizing the Potential of Mature Brands

Author:

As many drugs are reaching the patent cliff, strategies to extend the commercial life of mature brands is critical to today’s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

Author:

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from

How To: Stop “No” From Being a 4-Letter Word

Not too long ago, a colleague jokingly compared me to a consigliere. (Think Marlon Brando in “The Godfather”). He said he didn’t know how I got any work done, as people wander in and out of my office to speak

5 Things Pharma Professionals Need to Know About Big Data

Big Data has its roots in a set of statistical methods called econometrics A main feature of the finance, biology, and the social sciences is the apparent randomness of the behaviors being measured. Econometrics exists to distill the random and

Best Practices’ Hosting Medical Affairs Consortium Roundtable Thursday, Nov. 6

Author:

Best Practices designed the Medical Affairs Consortium to provide Medical Affairs leaders with a forum for sharing insights about the key challenges they face. The consortium has developed a mechanism for creating and sharing solutions through three virtual roundtable discussions

Big Data in Pharma: What is Big Data?

We are past the peak of the Big Data hypecycle, not least of all because about half of the content on the topic put out by marketing gurus, branding experts, and other non-practitioners has moved on from extolling Big Data

Pharma Companies Feeling the Heat From the Sunshine Act

Author:

Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years,

Thou Shalt Build Credibility But Plan for the Worst

Author:

As pharma companies plan for the launch of new products, much of the discussion centers around how to position a new drug or device to the rest of the world. Still, much of that same planning can be internalized and

Competitive Intelligence Guidelines & Policies Keeping Companies in the Safety Zone

Author:

Competitive Intelligence (CI) groups are instrumental in helping world-class companies to anticipate and respond strategically to external change. Primary and secondary competitive intelligence research helps organizations to improve their chances for success in today’s competitive business environment. While there are

Developing & Maintaining Strategic Professional & Trade Relations Functions

Author:

Professional and trade relations groups are critical for dealing with a company’s critical stakeholder groups, such as professional, payer, and patient organizations. Despite this, these groups still must show value within healthcare organizations, while external trends are constantly shaping the

The First 3 Commandments of Internal Branding

Author:

In the last blog post, I promised to bring greater detail to how pharma companies should brand a product internally before reaching out to the public. The first three “commandments” generally occur during Phase II of a planned drug launch, and provide

10 Commandments of Internal Brand Messaging For Pharma

Author:

Today’s brand leaders must communicate new disease state information to their own employees as well as to physicians, patients and payers. Most companies rely on established external communication practices to reach internal audiences, but leading brand teams develop specialized internal

SPECIAL: 2014-2015 Medical Affairs Consortium Survey Has Launched

Author:

As the healthcare landscape changes, the Medical Affairs function has begun to play increasingly important roles in clinical development, market education, and regulatory compliance. Now, more than ever, leaders can learn valuable lessons from their peers on how they overcome